Line up to six companies across valuation, growth, profitability, leverage, ownership and technicals. Best and worst per row are highlighted.
| Metric | ICICIGI | GICRE | STARHEALTH | NIACL | GODIGIT |
|---|---|---|---|---|---|
| Size & Price | |||||
| Market capitalisation | ₹78,041 Cr | ₹56,825 Cr | ₹31,649 Cr | ₹26,403 Cr | ₹23,697 Cr |
| Enterprise value | — | — | — | — | — |
| Revenue (TTM) | ₹26,625 Cr | ₹49,141 Cr | ₹17,371 Cr | ₹46,909 Cr | ₹10,377 Cr |
| EBITDA (TTM) | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| PAT (TTM) | ₹2,428 Cr | ₹8,901 Cr | ₹557 Cr | ₹717 Cr | ₹492 Cr |
| Current price | ₹1,563.00 | ₹323.90 | ₹537.70 | ₹160.21 | ₹256.30 |
| 1-day change | -1.7% | -2.19% | +0.57% | -4.08% | -1.44% |
| Avg volume (30d) | — | — | — | — | — |
| 52-week high | — | — | — | — | — |
| 52-week low | — | — | — | — | — |
| Distance from 52w high | — | — | — | — | — |
| Distance from 52w low | — | — | — | — | — |
| Valuation | |||||
| Price to earnings | 32.1× | 6.4× | 56.8× | 36.8× | 48.1× |
| Price to book | 4.6× | 1.0× | 4.2× | 1.1× | 5.1× |
| Price to sales | 2.9× | 1.2× | 1.8× | 0.6× | 2.3× |
| EV / EBITDA | — | — | — | — | — |
| Dividend yield | 1.31% | 4.09% | 0% | 2.06% | 0% |
| Earnings yield | 3.11% | 15.66% | 1.76% | 2.72% | 2.08% |
| PEG ratio | — | — | — | — | — |
| Book value / share | ₹337.9 | ₹338.0 | ₹129.0 | ₹149.4 | ₹50.2 |
| EPS (TTM) | ₹48.7 | ₹50.7 | ₹9.5 | ₹4.4 | ₹5.3 |
| Growth | |||||
| Sales growth (1y) | 12.9% | 8.2% | 11.4% | 13.2% | 7.6% |
| Sales growth (3y CAGR) | — | — | — | — | — |
| Sales growth (5y CAGR) | — | — | — | — | — |
| Profit growth (1y) | 10.5% | 30% | -13.8% | 39.2% | 28.1% |
| Profit growth (3y CAGR) | — | — | — | — | — |
| Profit growth (5y CAGR) | — | — | — | — | — |
| Qtr sales growth (YoY) | 12% | -1.3% | 14% | 2% | 8.3% |
| Qtr profit growth (YoY) | -46% | -31.1% | 21,729.4% | -162.2% | -37.5% |
| Profitability | |||||
| Operating margin | — | — | — | — | — |
| Net margin | 10.7% | 19.6% | 3.2% | 2.9% | 5.3% |
| Return on equity | 17.8% | 17.9% | 7.6% | 5.7% | 12.1% |
| Return on capital employed | — | — | — | — | — |
| Return on assets | 17.2% | 10.5% | 6.9% | 1.7% | 10.8% |
| ROE (3y avg) | 17.7% | 16.6% | 8.4% | 5% | 10.9% |
| ROCE (3y avg) | — | — | — | — | — |
| Leverage & Quality | |||||
| Debt to equity | — | — | — | — | — |
| Interest coverage | — | — | — | — | — |
| Current ratio | — | — | — | — | — |
| Working capital days | — | — | — | — | — |
| Ownership | |||||
| Promoter holding | 51.2% | 77.4% | 58% | 85.4% | 73% |
| Promoter pledge | 0% | 0% | 0% | 0% | 0% |
| FII holding | 21.5% | 2.4% | 16% | 1% | 8.2% |
| DII holding | 20.7% | 17.7% | 19.4% | 11.2% | 15% |
| Public holding | 6.6% | 2.4% | 6.5% | 2.4% | 3.8% |
| Promoter holding change (1y) | -0.24% | -5% | -0.03% | 0% | -0.1% |
| Technical | |||||
| 50-day moving average | — | — | — | — | — |
| 200-day moving average | — | — | — | — | — |
| Price vs 50 DMA | — | — | — | — | — |
| Price vs 200 DMA | — | — | — | — | — |
| RSI (14) | — | — | — | — | — |
| Return (1m) | — | — | — | — | — |
| Return (3m) | — | — | — | — | — |
| Return (6m) | — | — | — | — | — |
| Return (1y) | — | — | — | — | — |
| Return (3y CAGR) | — | — | — | — | — |
| Relative strength (1y) | — | — | — | — | — |
| Volatility (1y) | — | — | — | — | — |
| Beta | — | — | — | — | — |
best in row weakest in rowRows without a better/worse direction aren't highlighted.
Figures in ₹ crore except percentages and per-share amounts. Each column shows its filed reporting basis and exact period end.
| Line item | ICICIGIMar 2025 · 2025-03-31Standalone | GICREMar 2025 · 2025-03-31Consolidated | STARHEALTHMar 2025 · 2025-03-31Standalone |
|---|
| GODIGITMar 2025 · 2025-03-31Standalone |
|---|
| Revenue | 22,937 | 45,589 | 15,594 | 41,238 | 9,480 |
| Profit before tax | 3,321 | 9,563 | 861 | 1,023 | 425 |
| Tax | 813 | 2,131 | 215 | 50 | 0 |
| Tax % | 24.5% | 22.3% | 25% | 4.9% | 0% |
| PAT | 2,508 | 7,432 | 646 | 972 | 425 |
| PAT margin % | 10.9% | 16.3% | 4.1% | 2.4% | 4.5% |
| EPS (₹) | 50.7 | 42.4 | 11 | 6.3 | 4.6 |
A blank means that line was not filed or cannot be derived for that company. Compare periods and basis labels before reading across a row.